FDA 510(k)
FDA class 2
Substantially Equivalent
🇳🇱 Netherlands
MODIFICATION TO MAMMAPRINT
K Number: K081092
·
Decision Dec 11, 2009
Classifications
1
FEI Numbers
4
Registration Numbers
4
Same Product Code
9
Applicant Total
3
Review Days
603
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- MODIFICATION TO MAMMAPRINT
- K Number
- K081092
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.6040
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Agendia
- Date Received
- April 17, 2008
- Decision Date
- December 11, 2009
- Product Code
- NYI
- Advisory Committee
- Immunology
- Review Advisory Committee
- PA
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NYI | Classifier, Prognostic, Recurrence Risk Assessment, Rna Gene Expression, Breast Cancer | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NYI), ordered by most recent decision date.
MammaPrint FFPE NGS Kit
FDA 510(k)
FDA Class 2
·Immunology
MammaPrint
FDA 510(k)
FDA Class 2
·Immunology
MAMMAPRINT FFPE
FDA 510(k)
FDA Class 2
·Immunology
PROSIGNA BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
FDA 510(k)
FDA Class 2
·Immunology
PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
FDA 510(k)
FDA Class 2
·Immunology
MAMMAPRINT
FDA 510(k)
FDA Class 2
·Immunology